EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Crossref · journal-article

PREVALENCE AND DETERMINANT OF ANTIDIABETIC MEDICATION ADHERENCE IN JIGAWA STATE, NORTHWESTERN NIGERIA.

Musa Saulawa Ibrahim, Usaini A Abdullahi, Habib A Abdullahi

West African Journal of Allied Health Sciences · 2026 · Band 2 · Ausgabe 2

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Background Adherence to antidiabetic medication is crucial in the long-term management of diabetes mellitus. It could lead to optimum glycemic control and reduction in diabetes related mortality. However, there is lack of data on the subject in northern Nigeria. Objective: To determine the prevalence and determinants of antidiabetic medication adherence among patients with diabetes mellitus. Methods: A hospital-based cross-sectional study conducted among adults with diabetes visiting the Endocrinology clinic of Rasheed Shekoni Federal University Teaching Hospital (RSFUTH) Dutse, Jigawa state. The Morisky Medication Adherence Scale (MMAR) questionnaire was used to assess antidiabetic medication adherence. Independent factors affecting adherence were ascertained using multivariate logistic regression models. Results: The sample consists of 118 patients diagnosed with diabetes mellitus. There were 65 (55.1%) males and 53 (44.9%) females. The prevalence of antidiabetic medication adherence was 51.7%. Patients who are older (age >60 years), female, urban residents, having long standing disease (diagnosed with diabetes for >10 years) and not using insulin are more likely to be adherent. Furthermore, independent factors found to be related to adherence are having a tertiary level of education (AOR 7.76; CI: 1.80, 33.41), high monthly income (AOR 6.99; CI: 1.13, 43.11), and taking a combination of 2 medications (AOR 7.55; CI 2.29, 24.89). Conclusions: The adherence level to antidiabetic medication is relatively good in this study. Individuals with higher socioeconomic status and long- standing disease are more likely to be adherent. Clinicians should give more emphasis to providing counselling and health education to younger and apparently healthy patients who might have less perception of risk associated with diabetes.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Musa Saulawa Ibrahim, Usaini A Abdullahi, Habib A Abdullahi
Quelle
West African Journal of Allied Health Sciences
Publikation
2026-09-07
Band / Ausgabe
2 / 2
Seiten
Nicht angegeben
ISSN / ISBN
3115-4581, 3115-4573
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Musa Saulawa Ibrahim, Usaini A Abdullahi, Habib A Abdullahi (2026). PREVALENCE AND DETERMINANT OF ANTIDIABETIC MEDICATION ADHERENCE IN JIGAWA STATE, NORTHWESTERN NIGERIA. West African Journal of Allied Health Sciences, 2 (2). https://doi.org/10.67891/g8aqj956
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1